| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T193 |
0-238 |
Sentence |
denotes |
The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) . |
| TextSentencer_T193 |
0-238 |
Sentence |
denotes |
The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) . |
| T10152 |
0-238 |
Sentence |
denotes |
The existence of pathogenic autoantibodies is well established for several peripheral neurological syndromes including myasthenia gravis, Lambert-Eaton syndrome, Guillain-Barré syndrome, and acquired neuromyotonia (Vincent et al., 1999) . |
| TextSentencer_T194 |
239-377 |
Sentence |
denotes |
Involvement of pathogenic autoantibodies in a particular dis-ease has been defined by several lines of experimental and clinical evidence. |
| TextSentencer_T194 |
239-377 |
Sentence |
denotes |
Involvement of pathogenic autoantibodies in a particular dis-ease has been defined by several lines of experimental and clinical evidence. |
| T11998 |
239-377 |
Sentence |
denotes |
Involvement of pathogenic autoantibodies in a particular dis-ease has been defined by several lines of experimental and clinical evidence. |
